Compare $ACUT vs $ESLA | Chartloom

Compare

$ACUT vs $ESLA

Accustem Sciences Inc · Estrella Immunopharma Inc

ACUT

Accustem Sciences Inc

ESLA

Estrella Immunopharma Inc

Compare $ACUT vs $ESLA

Comparing Accustem Sciences Inc and Estrella Immunopharma Inc

ACUTAccustem Sciences Inc

ESLAEstrella Immunopharma Inc

ACUTAccustem Sciences Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.6%

52W performance

-67.3%

FCF yield

-50.9%

ESLAEstrella Immunopharma Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.5%

52W performance

-68.5%

FCF yield

-53.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACUT

ESLA

Detailed metrics comparison

ACUT

Accustem Sciences Inc

ESLA

Estrella Immunopharma Inc

Market Cap

ACUT$2M

ESLA$18M

Enterprise Value

ACUT$2M

ESLA$17M

Price

ACUT$0.15

ESLA$0.41

P/E Ratio

ACUTN/A

ESLAN/A

P/S Ratio

ACUT0.00x

ESLA0.00x

EV/Sales

ACUT0.00x

ESLA0.00x

EV/EBITDA

ACUT0.00x

ESLA0.00x

P/B Ratio

ACUT2.97x

ESLA141.63x

P/FCF Ratio

ACUTN/A

ESLAN/A

EV/FCF

ACUT-2.01x

ESLA-1.86x

PEG Ratio

ACUTN/A

ESLAN/A

Forward P/E (NTM)

ACUTN/A

ESLAN/A

Forward P/S (NTM)

ACUTN/A

ESLAN/A

Revenue (TTM)

ACUT$0

ESLA$0

Revenue Growth (YoY)

ACUTN/A

ESLAN/A

Forward Rev Growth

ACUT0.0%

ESLA0.0%

Gross Margin (TTM)

ACUT0.0%

ESLA0.0%

Operating Margin (TTM)

ACUT0.0%

ESLA0.0%

EBITDA Margin (TTM)

ACUT0.0%

ESLA0.0%

Net Margin (TTM)

ACUT0.0%

ESLA0.0%

FCF Margin (TTM)

ACUTN/A

ESLAN/A

Net Income (TTM)

ACUT$-2M

ESLA$-10M

FCF (TTM)

ACUT$-1M

ESLA$-9M

EPS (TTM)

ACUT-$0.10

ESLA-$0.23

ROE (TTM)

ACUT-21712.9%

ESLA-25911.0%

ROA (TTM)

ACUT-10530.0%

ESLA-32876.0%

ROIC (TTM)

ACUT-179413.5%

ESLA-25911.0%

Cash

ACUT$13K

ESLA$147K

Debt

ACUT$63K

ESLA$0

Net Cash/Debt

ACUT$-50K

ESLA$147K

Current Ratio (TTM)

ACUT0.02x

ESLA0.20x

Quick Ratio (TTM)

ACUT0.00x

ESLA0.02x

Debt/Equity (TTM)

ACUT0.27x

ESLA0.00x

Debt/Assets (TTM)

ACUT0.0%

ESLA0.0%

Interest Coverage (TTM)

ACUTN/A

ESLAN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

ESLA0.00x

Beta

ACUT1.88

ESLA0.98

52W Performance

ACUT-67.3%

ESLA-68.5%

YTD Performance

ACUT-75.6%

ESLA-70.5%

% from 52W High

ACUT-93.7%

ESLA-87.0%

% from 52W Low

ACUT26.0%

ESLA33.0%

Asset Turnover (TTM)

ACUT0.00x

ESLA0.00x

FCF Yield (TTM)

ACUT-50.9%

ESLA-53.2%

Earnings Yield (TTM)

ACUT-69.8%

ESLA-56.8%

Dividend Yield (TTM)

ACUTN/A

ESLAN/A

Rule of 40

ACUT0.0

ESLA0.0

EV/GP/RG

ACUTN/A

ESLAN/A

Ticker research

View ACUT research View ESLA research

Metric	ACUT Accustem Sciences Inc	ESLA Estrella Immunopharma Inc
Market & Valuation
Market Cap	$2M	$18M
Enterprise Value	$2M	$17M
Price	$0.15	$0.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.97x	141.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-1.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-2M	$-10M
FCF (TTM)	$-1M	$-9M
EPS (TTM)	-$0.10	-$0.23
ROE (TTM)	-21712.9%	-25911.0%
ROA (TTM)	-10530.0%	-32876.0%
ROIC (TTM)	-179413.5%	-25911.0%
Financial Health
Cash	$13K	$147K
Debt	$63K	$0
Net Cash/Debt	$-50K	$147K
Current Ratio (TTM)	0.02x	0.20x
Quick Ratio (TTM)	0.00x	0.02x
Debt/Equity (TTM)	0.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	0.98
52W Performance	-67.3%	-68.5%
YTD Performance	-75.6%	-70.5%
% from 52W High	-93.7%	-87.0%
% from 52W Low	26.0%	33.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-50.9%	-53.2%
Earnings Yield (TTM)	-69.8%	-56.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACUT research	View ESLA research

Valuation

P/S Ratio

ACUT

0.00x

ESLA

0.00x

EV/FCF

ACUT

-2.01x

ESLA

-1.86x

Growth & revenue

Forward Revenue Growth

ACUT

0.0%

ESLA

0.0%

Profitability & performance

Gross Margin

ACUT

0.0%

ESLA

0.0%

ROE

ACUT

-21712.9%

ESLA

-25911.0%

FCF Yield %

ACUT

-50.9%

ESLA

-53.2%

52-Week Performance

ACUT

-67.3%

ESLA

-68.5%

Detailed metrics comparison

ACUT

Accustem Sciences Inc

ESLA

Estrella Immunopharma Inc

Market Cap

ACUT$2M

ESLA$18M

Enterprise Value

ACUT$2M

ESLA$17M

Price

ACUT$0.15

ESLA$0.41

P/E Ratio

ACUTN/A

ESLAN/A

P/S Ratio

ACUT0.00x

ESLA0.00x

EV/Sales

ACUT0.00x

ESLA0.00x

EV/EBITDA

ACUT0.00x

ESLA0.00x

P/B Ratio

ACUT2.97x

ESLA141.63x

P/FCF Ratio

ACUTN/A

ESLAN/A

EV/FCF

ACUT-2.01x

ESLA-1.86x

PEG Ratio

ACUTN/A

ESLAN/A

Forward P/E (NTM)

ACUTN/A

ESLAN/A

Forward P/S (NTM)

ACUTN/A

ESLAN/A

Revenue (TTM)

ACUT$0

ESLA$0

Revenue Growth (YoY)

ACUTN/A

ESLAN/A

Forward Rev Growth

ACUT0.0%

ESLA0.0%

Gross Margin (TTM)

ACUT0.0%

ESLA0.0%

Operating Margin (TTM)

ACUT0.0%

ESLA0.0%

EBITDA Margin (TTM)

ACUT0.0%

ESLA0.0%

Net Margin (TTM)

ACUT0.0%

ESLA0.0%

FCF Margin (TTM)

ACUTN/A

ESLAN/A

Net Income (TTM)

ACUT$-2M

ESLA$-10M

FCF (TTM)

ACUT$-1M

ESLA$-9M

EPS (TTM)

ACUT-$0.10

ESLA-$0.23

ROE (TTM)

ACUT-21712.9%

ESLA-25911.0%

ROA (TTM)

ACUT-10530.0%

ESLA-32876.0%

ROIC (TTM)

ACUT-179413.5%

ESLA-25911.0%

Cash

ACUT$13K

ESLA$147K

Debt

ACUT$63K

ESLA$0

Net Cash/Debt

ACUT$-50K

ESLA$147K

Current Ratio (TTM)

ACUT0.02x

ESLA0.20x

Quick Ratio (TTM)

ACUT0.00x

ESLA0.02x

Debt/Equity (TTM)

ACUT0.27x

ESLA0.00x

Debt/Assets (TTM)

ACUT0.0%

ESLA0.0%

Interest Coverage (TTM)

ACUTN/A

ESLAN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

ESLA0.00x

Beta

ACUT1.88

ESLA0.98

52W Performance

ACUT-67.3%

ESLA-68.5%

YTD Performance

ACUT-75.6%

ESLA-70.5%

% from 52W High

ACUT-93.7%

ESLA-87.0%

% from 52W Low

ACUT26.0%

ESLA33.0%

Asset Turnover (TTM)

ACUT0.00x

ESLA0.00x

FCF Yield (TTM)

ACUT-50.9%

ESLA-53.2%

Earnings Yield (TTM)

ACUT-69.8%

ESLA-56.8%

Dividend Yield (TTM)

ACUTN/A

ESLAN/A

Rule of 40

ACUT0.0

ESLA0.0

EV/GP/RG

ACUTN/A

ESLAN/A

Ticker research

View ACUT research View ESLA research

Metric	ACUT Accustem Sciences Inc	ESLA Estrella Immunopharma Inc
Market & Valuation
Market Cap	$2M	$18M
Enterprise Value	$2M	$17M
Price	$0.15	$0.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.97x	141.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-1.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-2M	$-10M
FCF (TTM)	$-1M	$-9M
EPS (TTM)	-$0.10	-$0.23
ROE (TTM)	-21712.9%	-25911.0%
ROA (TTM)	-10530.0%	-32876.0%
ROIC (TTM)	-179413.5%	-25911.0%
Financial Health
Cash	$13K	$147K
Debt	$63K	$0
Net Cash/Debt	$-50K	$147K
Current Ratio (TTM)	0.02x	0.20x
Quick Ratio (TTM)	0.00x	0.02x
Debt/Equity (TTM)	0.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	0.98
52W Performance	-67.3%	-68.5%
YTD Performance	-75.6%	-70.5%
% from 52W High	-93.7%	-87.0%
% from 52W Low	26.0%	33.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-50.9%	-53.2%
Earnings Yield (TTM)	-69.8%	-56.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACUT research	View ESLA research